Dysregulation of circulating sTie2 and sHER2 in HIV-infected women with preeclampsia

References

• UNICEF Eastern and Southern Africa. Every three minutes a teenage girl is infected by HIV. New York: UNICEF; 2018.
   Google Scholar
• Statistics. Mid-year population estimates-Statistics South Africa. Statistics South Africa [ Internet]; 2018. Available from: https://www.statssa.gov.za/publications/P0302/P03022017.pdf
   Google Scholar
• Saving mother’s reports 2014-2016. The report of the National Committee on Confidential Enquiries into Maternal Deaths. National Department of Health. Pretoria: Saving mother; 2017
   Google Scholar
• Staff AC, Harsem NK, Braekke K, et al. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2009;143(1):29–33.
   PubMed Web of Science ®Google Scholar
• Whittington CM, Danastas K, Grau GE, et al. Expression of VEGF 111 and other VEGF-A variants in the rat uterus is correlated with stage of pregnancy. J Comp Physiol B. 2017;187(2):353–360.
   PubMed Web of Science ®Google Scholar
• Cerdeira AS, Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med. 2012;2(11):a006585.
   PubMed Web of Science ®Google Scholar
• Thakoordeen S, Moodley J, Naicker T. Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and −2 in HIV associated preeclampsia. Hypertens Pregnancy. 2017;36(2):168–174.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Karumanchi SA, editors. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33–46.
   PubMed Web of Science ®Google Scholar
• Abdel-Hamid AA, Firgany AE-DL, Mesbah Y, et al. Vascular and cellular changes accompany altered expression of angiopoietins in placenta of non-complicated ART pregnancies. Exp Mol Pathol. 2017;102(2):284–289.
   PubMed Web of Science ®Google Scholar
• Brindle NPJ, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006;98(8):1014–1023.
   PubMed Web of Science ®Google Scholar
• Lee P-H, Kim B-G, Seo H-J, et al. Circulating angiopoietin-1 and-2 in patients with stable and exacerbated asthma. Ann Allergy Asthma Immunol. 2016;116(4):339–343.
   PubMed Web of Science ®Google Scholar
• Reusch P, Barleon B, Weindel K, et al. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis. 2001;4(2):123–131.
   PubMedGoogle Scholar
• Alawo DO, Tahir TA, Fischer M, et al. Regulation of angiopoietin signalling by soluble Tie2 ectodomain and engineered ligand trap. Sci Rep. 2017;7(1):3658.
   PubMedGoogle Scholar
• Maternal Metabolism GR. Vascular adaptation in pregnancy: the PPAR link. Trends Endocrinol Metab. 2017;28(1):73–84.
   PubMed Web of Science ®Google Scholar
• Espelin CW, Leonard SC, Geretti E, et al. Dual HER2 targeting with trastuzumab and liposome-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer. Cancer Res. 2016. canres. 1518.2015.
   PubMed Web of Science ®Google Scholar
• Cosentino-Boehm AL, Lafky JM, Greenwood TM, et al. Soluble human epidermal growth factor receptor 2 (sHER2) as a potential risk assessment, screening, and diagnostic biomarker of lung adenocarcinoma. Diagnostics (Basel). 2013;3(1):13–32.
   PubMedGoogle Scholar
• Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 2017;9(5):52.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Kappou D, Sifakis S, Konstantinidou A, et al. Role of the angiopoietin/Tie system in pregnancy. Exp Ther Med. 2015;9(4):1091.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic JP, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med. 2008;21(6):389–402.
   PubMed Web of Science ®Google Scholar
• Kim I, Kim JH, Moon SO, et al. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3ʹ-kinase/Akt signal transduction pathway. Oncogene. 2000;19(39):4549–4552.
   PubMed Web of Science ®Google Scholar
• Hirokoshi K, Maeshima Y, Kobayashi K, et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia*. Am J Hypertens. 2005;18(9):1181–1188.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Karalis I, Al Yemeni E, et al. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost. 2005;94(05):1071–1076.
   PubMedGoogle Scholar
• Aref S, Goda H, Abdelaal E. Circulating vascular growth factor (VEGF) Angiopoietin-1 (Angi-1) and soluble Tie-2 receptor in pregnancy complicated with pre-eclampsia: a prospective study. J Obstet Gynaecol India. 2013;63(5):316–320.
   PubMedGoogle Scholar
• Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015;5:10.
   Web of Science ®Google Scholar
• Monte S. Biochemical markers for prediction of preclampsia: review of the literature. J Prenat Med. 2011;5:69–77.
   PubMedGoogle Scholar
• Sung JF, Fan X, Dhal S, et al. Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling. J Clin Endocrinol Metab. 2011;96(7):E1148–E52.
   PubMed Web of Science ®Google Scholar
• Findley CM, Mitchell RG, Duscha BD, et al. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;52(5):387.
   PubMed Web of Science ®Google Scholar
• Meden H, Fattahi-Meibodi A, Marx D. ELISA-based quantification of p105 (c-erbB-2, HER2/neu) in serum of ovarian carcinoma. Ovarian Cancer. 2000;125–133.
   Google Scholar
• Meden H, Marx D, Raab T, et al. WEGF-R and over expression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value. J Obstet Gynaecol. 1995;21:167-178.
   Google Scholar
• Mielke S, Meden H, Kuhn W. Expression of the c-erbB-2-encoded oncoprotein p185 (HER-2/neu) in pregnancy as a model for oncogene-induced carcinogenesis. Med Hypotheses. 1998;50(5):359–362.
   PubMed Web of Science ®Google Scholar
• Tse C, Lefevre G, Berkane N, et al. Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia. Clin Chem Lab Med. 2004;42(2):142–146.
   PubMed Web of Science ®Google Scholar
• McMichael AJ, Borrow P, Tomaras GD, et al. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010;10(1):11–23.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Kell DB. Immunological tolerance, pregnancy, and preeclampsia: the roles of semen microbes and the father. Front Med (Lausanne). 2018;4:239.
   PubMed Web of Science ®Google Scholar
• Govender N, Naicker T, Moodley J. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovasc J Afr. 2013;24(5):174–179.
   PubMed Web of Science ®Google Scholar
• Kalumba VMS, Moodley J, Naidoo TD. Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case–control study. Cardiovasc J Afr. 2013;24:24–27.
   PubMed Web of Science ®Google Scholar
• Patel D, Thorne C, Fiore S, et al. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr. 2005;40(1):116–118.
   PubMed Web of Science ®Google Scholar
• Sansone M, Sarno L, Saccone G, et al. Risk of preeclampsia in human immunodeficiency virus-infected pregnant women. Obstet Gynecol. 2016;127(6):1027–1032.
   PubMed Web of Science ®Google Scholar
• Sebitloane HM, Moodley J, Sartorius B. Associations between HIV, highly active anti‐retroviral therapy, and hypertensive disorders of pregnancy among maternal deaths in South Africa 2011–2013. Int J Gynecol Obstet. 2017;136(2):195–199.
   PubMed Web of Science ®Google Scholar